Stonebridge Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,950	Closed	-$239K	–	117
2019 Q2	$239K	Buy	8,950 +350	+4%	+$8.94K	0.09%	114
2019 Q1	$231K	Sell	8,600 -5,605	-39%	-$131K	0.08%	122
2018 Q4	$230K	Buy	14,205 +1,775	+14%	+$34.5K	0.09%	115
2018 Q3	$258K	Sell	12,430 -400	-3%	-$6.29K	0.09%	110
2018 Q2	$213K	Buy	+12,830	New	+$229K	0.08%	118
2016 Q2	–	Sell	-24,110	Closed	-$675K	–	131
2016 Q1	$675K	Buy	24,110 +14,720	+157%	+$321K	0.29%	59
2015 Q4	$334K	Buy	+9,390	New	+$331K	0.14%	120
2015 Q3	–	Sell	-6,930	Closed	-$290K	–	160
2015 Q2	$290K	Hold	6,930	–	–	0.12%	131
2015 Q1	$226K	Hold	6,930	–	–	0.09%	148
2014 Q4	$220K	Buy	+6,930	New	+$197K	0.08%	162